Merck to seek emergency use for COVID-19 antiviral pill that cuts severe outcomes by 50 percent
By
Alicia Lasek
Oct 04, 2021
Molnupiravir has reduced COVID-19 deaths and hospitalizations by half in a new clinical trial. An orally delivered drug could offer unprecedented treatment convenience, the drug’s developers say.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
Opt-in COVID vaccine program kicks off; Feds partner with CVS, Walgreens
By
Alicia Lasek
Oct 19, 2020
Long-term care facilities nationwide can voluntarily opt in to a free pharmacy partnership program that will provide and administer future COVID-19 vaccines on site, federal officials announced Friday.